SRY Labs
SRY Labs' purity-focus record is strongest in Tirzepatide and Retatrutide, where recent runs mostly pass after earlier misses. Results are dispersed rather than uniform: Tesamorelin and TB-500 show repeated purity or fill problems, while high volume and current testing are offset by frequent batch-ID gaps.
We investigated who actually operates SRY Labs — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including SRY Labs rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 20 Jul 2026 | Pass | Tirzepatide SRY Labs | lab name | View COA | |||
| 8 Jun 2026 | Pass | Retatrutide SRY Labs | lab name | View COA | |||
| 8 May 2026 | Pass | Cagrilintide SRY Labs | lab name | View COA | |||
| 6 May 2026 | Pass | Tirzepatide SRY Labs | lab name | View COA | |||
| 23 Apr 2026 | Pass | Tirzepatide SRY Labs | lab name | View COA | |||
| 25 Mar 2026 | Pass | Retatrutide SRY Labs | lab name | View COA | |||
| 25 Mar 2026 | Pass | Tirzepatide SRY Labs | lab name | View COA | |||
| 19 Mar 2026 | Pass | Retatrutide SRY Labs | lab name | View COA | |||
| 13 Mar 2026 | Pass | Cagrilintide SRY Labs | lab name | View COA | |||
| 6 Mar 2026 | Fail | Sermorelin SRY Labs | lab name | View COA | |||
About SRY Labs test results from Finnrick
SRY Labs is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 122 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible SRY Labs peptides in this dataset are Tirzepatide (36 tests) and Retatrutide (31 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 122 recent tests.